Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor

Ashkenazi, 1999, Apoptosis control by death and decoy receptors, Curr. Opin. Cell Biol, 11, 255, 10.1016/S0955-0674(99)80034-9

Brunk, 1997, Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts, Free Radic. Biol. Med, 23, 616, 10.1016/S0891-5849(97)00007-5

Chautan, 1999, Interdigital cell death can occur through a necrotic and caspase-independent pathway, Curr. Biol, 9, 967, 10.1016/S0960-9822(99)80425-4

Deiss, 1996, Catepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1, and TNF-α, EMBO J., 15, 3861, 10.1002/j.1460-2075.1996.tb00760.x

Deussing, 1998, Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation, Proc. Natl. Acad. Sci. USA, 95, 4516, 10.1073/pnas.95.8.4516

Doerfler, 2000, Caspase Enzyme activity is not essential for apoptosis during thymocyte development, J. Immunol., 164, 4071, 10.4049/jimmunol.164.8.4071

Eguchi, 1997, Intracellular ATP levels determine cell death fate by apoptosis or necrosis, Cancer Res, 57, 1835

Ellis, 1986, Genetic control of programmed cell death in nematode C. elegans, Cell, 44, 817, 10.1016/0092-8674(86)90004-8

Faraco, 1999, Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage, Biochem. Biophys. Res. Commun, 261, 385, 10.1006/bbrc.1999.1042

Garcia-Calvo, 1998, Inhibition of human caspases by peptide-based and macromolecular inhibitors, J. Biol. Chem, 273, 32608, 10.1074/jbc.273.49.32608

Grimm, 1999, Apoptosis and the proteasome, Results Probl. Cell Differ, 23, 209, 10.1007/978-3-540-69184-6_10

Guicciardi, 2000, Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c, J. Clin. Invest, 106, 1127, 10.1172/JCI9914

Hirt, 2000, Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms, J. Immunol, 164, 6520, 10.4049/jimmunol.164.12.6520

Jäättelä, 1999, Escaping cell deathsurvival proteins in cancer, Exp. Cell Res., 248, 30, 10.1006/excr.1999.4455

Jäättelä, 1995, Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells, Oncogene, 10, 2297

Jäättelä, 1996, A20 zinc finger protein inhibits TNF and IL-1 signaling, J. Immunol., 156, 1166, 10.4049/jimmunol.156.3.1166

Jäättelä, 1998, Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases, EMBO J., 17, 6124, 10.1093/emboj/17.21.6124

Jones, 1998, Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line, Am. J. Physiol, 275, G723

Kawahara, 1998, Caspase-independent cell killing by Fas-associated protein with death domain, J. Cell Biol, 143, 1353, 10.1083/jcb.143.5.1353

Khwaja, 1999, Resistance to the cytotoxic effects of tumor necrosis factor α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway, J. Biol. Chem, 274, 36817, 10.1074/jbc.274.51.36817

Kos, 1998, Cysteine proteinases and their endogenous inhibitorstarget proteins for prognosis, diagnosis and therapy in cancer, Oncol. Rep, 5, 1349

Kuopio, 1998, Cysteine proteinase inhibitor cystatin A in breast cancer, Cancer Res, 58, 432

Latta, 2000, Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1–mediated hepatic apoptosis, J. Exp. Med, 191, 1975, 10.1084/jem.191.11.1975

Lavoie, 1998, E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk, J. Cell Biol, 140, 637, 10.1083/jcb.140.3.637

Leist, 1994, Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest, J. Immunol, 153, 1778, 10.4049/jimmunol.153.4.1778

Leist, 1997, Intracellular adenosine triphosphate (ATP) concentrationa switch in the decision between apoptosis and necrosis, J. Exp. Med, 185, 1481, 10.1084/jem.185.8.1481

Li, 2000, Induction of cell death by the lysosomotropic detergent MSDH, FEBS Lett, 470, 35, 10.1016/S0014-5793(00)01286-2

Lowe, 2000, Apoptosis in cancer, Carcinogenesis, 21, 485, 10.1093/carcin/21.3.485

Luschen, 2000, Sensitization to death receptor cytotoxicity by inhibition of FADD/Caspase signalingrequirement of cell cycle progression, J. Biol. Chem, 275, 24670, 10.1074/jbc.M003280200

Mai, 2000, Cell surface complex of cathepsin B/annexin II tetramer in malignant progression, Biochim. Biophys. Acta, 1477, 215, 10.1016/S0167-4838(99)00274-5

Mathiasen, 1999, Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53, Cancer Res, 59, 4848

Nylandsted, 2000, Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2, Proc. Natl. Acad. Sci. USA, 97, 7871, 10.1073/pnas.97.14.7871

Roberg, 1998, Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes, Am. J. Pathol, 152, 1151

Roberts, 1997, Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes, Gastroenterology, 113, 1714, 10.1053/gast.1997.v113.pm9352877

Roberts, 1999, Cathepsins as effector proteases in hepatocyte apoptosis, Cell Biochem. Biophys, 30, 71, 10.1007/BF02737885

Ruggiero, 1987, Protection from tumor necrosis factor cytotoxicity by protease inhibitors, Cell. Immunol., 107, 317, 10.1016/0008-8749(87)90240-1

Schotte, 1999, Non-specific effects of methyl ketone peptide inhibitors of caspases, FEBS Lett, 442, 117, 10.1016/S0014-5793(98)01640-8

Shi, 1999, Cathepsin S required for normal MHC class II peptide loading and germinal center development, Immunity, 10, 197, 10.1016/S1074-7613(00)80020-5

Sloane, 1990, Cathepsin B and its endogenous inhibitorsthe role in tumor malignancy, Cancer Metastasis Rev, 9, 333, 10.1007/BF00049523

Soengas, 2001, Inactivation of the apoptosis effector Apaf-1 in malignant melanoma, Nature, 409, 207, 10.1038/35051606

Stoka, 2001, Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route, J. Biol. Chem, 276, 3149, 10.1074/jbc.M008944200

Tartaglia, 1991, The two different receptors for tumor necrosis factor mediate distinct cellular responses, Proc. Natl. Acad. Sci. USA, 88, 9292, 10.1073/pnas.88.20.9292

Thornberry, 1998, Caspasesenemies within, Science, 281, 1312, 10.1126/science.281.5381.1312

Tsujimoto, 1985, Tumor necrosis factorspecific binding and internalization in sensitive and resistant cells, Proc. Natl. Acad. Sci. USA, 82, 7626, 10.1073/pnas.82.22.7626

Vanags, 1996, Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis, J. Biol. Chem, 271, 31075, 10.1074/jbc.271.49.31075

Vercammen, 1998, Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor, J. Exp. Med, 187, 1477, 10.1084/jem.187.9.1477

Wallach, 1999, Tumor necrosis factor receptor and Fas signaling mechanisms, Annu. Rev. Immunol, 17, 331, 10.1146/annurev.immunol.17.1.331

Wissing, 1997, Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis, Proc. Natl. Acad. Sci. USA, 94, 5073, 10.1073/pnas.94.10.5073

Wright, 1994, Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation, J. Exp. Med., 180, 2113, 10.1084/jem.180.6.2113

Wright, 1997, Activation of CPP32-like proteases is not sufficient to trigger apoptosisinhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity, J. Exp. Med., 186, 1107, 10.1084/jem.186.7.1107

Wyllie, 2001, More than one way to go, Proc. Natl. Acad. Sci. USA, 98, 11, 10.1073/pnas.98.1.11